In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has raced higher following the release of an update.
At the time of writing the cannabis company’s shares are up 7% to 51 cents.
Why is the Althea share price on a high today?
This morning the medicinal cannabis company provided an update on the Bristol site of its wholly owned subsidiary, MyAccess Clinics.
According to the release, the site has been registered with and received a licence from the Care Quality Commission (CQC). This is the independent regulator of health and social care in England.
This means that MyAccess Clinics’ Bristol site is the second medical cannabis clinic in the UK to be granted a CQC licence. It is also the first located outside of London with the licence.
Management believes that the approval of the CQC licence is a significant milestone for both MyAccess Clinics and the UK medical cannabis market. This is because it “provides further regulatory acceptance of cannabis-based medicines being utilised as a treatment option for chronic health conditions.”
The release explains that CQC registration also allows for domiciliary care. This means MyAccess Clinics prescribers are now available for home care services. Another bonus is that the CQC registration can extend to further clinics as part of the company’s expansion plans.
MyAccess Clinics’ clinical director, Graham Woodward, was delighted with the news.
He said: “We’re delighted to have received our CQC registration and licence, which I am confident will be a turning point for patients who have so far been unable to access medical cannabis in the UK.”
“The CQC licence will allow our physicians to prescribe with absolute confidence, along with now being able to assess patients in their own homes. I also trust this development will bring renewed hope for the reported 1.4 million people in the UK using ‘street cannabis’ to treat their chronic health conditions, now that they will have increased access to expert care and high-quality medical cannabis products,” he added.
We hear it over and over from investors, "I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I'd be sitting on a gold mine!" And it's true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Invest like Warren Buffett and buy and hold these excellent ASX shares – July 16, 2020 6:09pm
- Why these excellent ASX healthcare shares could be long-term market beaters – July 16, 2020 5:55pm
- 3 must-buy ASX growth shares for July – July 16, 2020 3:42pm